Naviter Wealth LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Naviter Wealth LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,095 shares of the healthcare conglomerate’s stock after acquiring an additional 968 shares during the period. Naviter Wealth LLC’s holdings in UnitedHealth Group were worth $3,510,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after purchasing an additional 250,291 shares in the last quarter. Wellington Management Group LLP lifted its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares in the last quarter. Capital Research Global Investors lifted its stake in UnitedHealth Group by 2.2% during the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after purchasing an additional 324,733 shares in the last quarter. Capital International Investors raised its stake in shares of UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after acquiring an additional 542,424 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $5,802,231,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $498.13 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The business’s 50-day moving average price is $498.40 and its 200 day moving average price is $501.35. The firm has a market cap of $458.47 billion, a P/E ratio of 30.45, a P/E/G ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm earned $6.26 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.69%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

Several analysts have recently issued reports on UNH shares. Robert W. Baird started coverage on UnitedHealth Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $597.00 price objective on the stock. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research note on Wednesday, June 5th. Piper Sandler increased their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Finally, Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.